To assess the global and China's colorectal cancer (CRC) burden using GLOBOCAN 2022 data, focusing on incidence, mortality, and demographic disparities, and to project future CRC incidence and mortality through 2050.
Key Findings:
CRC is the second leading cause of cancer-related mortality worldwide, with specific statistics indicating a significant burden.
Notable increase in CRC incidence among individuals under 50 years of age, with data showing a percentage increase.
Disparities exist in CRC burden based on geographic, demographic, and socioeconomic factors, highlighting areas for targeted intervention.
Interpretation:
The findings highlight the need for refined CRC prevention strategies, particularly targeting high-risk populations and regions with significant disease burdens, to align with global health initiatives.
Limitations:
Data may not fully reflect post-pandemic developments, potentially skewing the understanding of current trends.
Potential misalignment in screening age thresholds and resource allocation may hinder effective intervention strategies.
Conclusion:
This study provides crucial data to inform CRC prevention and control strategies globally, aiming to reduce preventable cancer deaths and align with WHO's health objectives.
